- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Unresectable Renal Pelvis Urothelial Carcinoma
Total 3059 results
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingUnresectable Hepatocellular CarcinomaUnited States
-
Guangzhou University of Chinese MedicineCompletedUnresectable Hepatocellular CarcinomaChina
-
National Cancer Institute (NCI)CompletedHepatocellular Carcinoma | Unresectable Hepatocellular CarcinomaUnited States
-
AstraZenecaApproved for marketing
-
University of MiamiSurefire Medical, Inc.WithdrawnUnresectable Hepatocellular CarcinomaUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedUnresectable Hepatocellular CarcinomaBelgium, Italy, United States, Germany, Canada
-
University of Roma La SapienzaNot yet recruitingNon-muscle-invasive Bladder Cancer | Non-Muscle Invasive Bladder Urothelial Carcinoma | High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
-
Australian and New Zealand Urogenital and Prostate...Merck Sharp & Dohme LLC; AmgenActive, not recruitingRenal Cell Carcinoma, Clear Cell | Metastatic Kidney CancerAustralia
-
LG ChemNot yet recruitingUrothelial Carcinoma | Malignant Melanoma | Non-small Cell Lung Cancer(NSCLC) | Head and Neck Squamous Cell Carcinoma(HNSCC) | Renal Cell Carcinoma(RCC)
-
National Cancer Institute (NCI)CompletedRecurrent Bladder Cancer | Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter | Stage IV Bladder Cancer | Transitional Cell Carcinoma of the Bladder | Distal Urethral Cancer | Proximal Urethral Cancer | Recurrent Urethral Cancer | Urethral Cancer Associated With Invasive Bladder CancerUnited States, China, Korea, Republic of
-
SCRI Development Innovations, LLCCelgeneTerminatedTransitional Cell Carcinoma | Bladder Cancer | Urothelial CarcinomaUnited States
-
Rain Oncology IncWithdrawnMilademetan in Combination With Atezolizumab in Patients With Advanced Solid Tumors With CDKN2A LossMelanoma | Renal Cell Carcinoma | Gastric Cancer | NSCLC | Mesothelioma | Advanced Solid Tumor | Pancreas Adenocarcinoma | Urothelial Carcinoma Bladder | HNSCC | CDKN2A
-
ALX Oncology Inc.RecruitingBladder Cancer | Urothelial CarcinomaUnited States
-
Lawrence FongCellSight Technologies, Inc.Terminated
-
Seoul National University HospitalUnknownUrothelial CarcinomaKorea, Republic of
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineTerminated
-
University of MichiganPfizerTerminatedBladder Cancer | Urothelial CarcinomaUnited States
-
National Taiwan University HospitalUnknown
-
Incyte CorporationCompletedMelanoma | Breast Cancer | Head and Neck Cancer | Pancreatic Cancer | Lung Cancer | Endometrial Cancer | Solid Tumors | Renal Cell Carcinoma (RCC) | Colorectal Cancer (CRC) | UC (Urothelial Cancer) | MMR-deficient TumorsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); ExelixisActive, not recruitingRenal Cell Carcinoma | Metastatic Renal Cell Carcinoma | Stage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Malignant Neoplasms of Urinary Tract | Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3... and other conditionsUnited States
-
Novartis PharmaceuticalsCompletedAdenocarcinoma | Carcinoma | Renal Cell | Non Clear Cell Renal Carcinoma | Papillary Cell Renal CarcinomaFrance, Italy, Belgium, Germany, Spain, Poland
-
National Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Localized Extrahepatic Bile Duct Cancer | Localized Gallbladder Cancer | Localized Resectable Adult Primary Liver Cancer | Localized Unresectable Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Recurrent Extrahepatic Bile Duct Cancer | Recurrent... and other conditionsUnited States
-
VA Office of Research and DevelopmentBayerNot yet recruitingAdvanced Urothelial CarcinomaUnited States
-
The Methodist Hospital Research InstitutePfizerRecruitingUrothelial Carcinoma BladderUnited States
-
Leiden University Medical CenterRecruitingUrothelial Carcinoma | Sarcoma,Soft TissueNetherlands
-
SCRI Development Innovations, LLCNovartisCompleted
-
Yonsei UniversityCompletedHepatocellular Carcinoma, Unresectable, AdvancedKorea, Republic of
-
Eisai Co., Ltd.CompletedUnresectable Hepatocellular Carcinoma (HCC)China
-
Celldex TherapeuticsTerminatedKidney Neoplasms | Metastatic Renal Cell Carcinoma | Ovarian Clear Cell Carcinoma | Papillary Renal Cell Carcinoma | Renal Cell Carcinoma (RCC) | Clear-cell Renal Cell CarcinomaUnited States
-
Mabwell (Shanghai) Bioscience Co., Ltd.Not yet recruitingAdvanced Clear Cell Renal Cell Carcinoma
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingStage III Intrahepatic Cholangiocarcinoma AJCC v8 | Unresectable Hepatocellular Carcinoma | Stage III Hepatocellular Carcinoma AJCC v8 | Stage IV Hepatocellular Carcinoma AJCC v8 | Stage IV Intrahepatic Cholangiocarcinoma AJCC v8 | Unresectable Intrahepatic CholangiocarcinomaUnited States
-
Guarionex J. DecastroSanofiActive, not recruitingUrothelial Carcinoma of the Urinary BladderUnited States
-
Mayo ClinicNational Cancer Institute (NCI)Active, not recruitingMetastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Sarcomatoid Renal Cell Carcinoma | Stage IV Renal Cell Cancer | Chromophobe Renal Cell Carcinoma | Papillary Renal Cell Carcinoma | Kidney Medullary Carcinoma | Kidney Oncocytoma | Carcinoma of the Collecting Ducts of BelliniUnited States
-
Fudan UniversityUnknownHepatocellular Carcinoma | UnresectableChina
-
University of Michigan Rogel Cancer CenterTerminated
-
Kinnate BiopharmaActive, not recruitingIntrahepatic Cholangiocarcinoma | Urothelial Carcinoma | Solid Tumor, AdultUnited States, Korea, Republic of, Taiwan, China, Denmark, Spain
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedBladder Cancer | Transitional Cell Cancer of the Renal Pelvis and Ureter | Urethral CancerUnited States, South Africa
-
Agensys, Inc.CompletedCarcinoma, Renal Cell | Renal Cell Carcinoma of Papillary Histology | Renal Cell Carcinoma With Clear Cell Histology | Renal Cell Carcinoma With Non-Clear Cell HistologyUnited States, Canada
-
RenJi HospitalRecruitingUpper Urinary Tract Urothelial Carcinoma | Kidney Preservation | HER-2 ADC | PD-1antibodyChina
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingBladder Cancer | Non-Muscle-Invasive Urothelial CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Melanoma | Unresectable Melanoma | Clinical Stage III Cutaneous Melanoma AJCC v8 | Metastatic Merkel Cell Carcinoma | Metastatic Skin Squamous Cell Carcinoma | Clinical Stage IV Cutaneous Melanoma AJCC v8 | Metastatic Basal Cell Carcinoma | Unresectable Merkel Cell Carcinoma | Unresectable... and other conditionsUnited States
-
University of WashingtonBreast Cancer Research FoundationNot yet recruitingAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Metastatic HER2-Negative Breast Carcinoma | Metastatic Hormone Receptor-Positive Breast Carcinoma | Locally Advanced Unresectable HER2-Negative Breast Carcinoma | Locally Advanced Unresectable Hormone Receptor-Positive...United States
-
Associació per a la Recerca Oncologica, SpainUnknownUrothelium Transitional Cell CarcinomaSpain, Netherlands
-
Ludwig-Maximilians - University of MunichCompletedProstate Cancer | Urothelial Carcinoma | Renal Cell Cancer | Fear of Cancer Recurrence | Testicle CancerGermany
-
IRCCS San RaffaeleRecruiting
-
Pusan National University Yangsan HospitalRecruitingUrothelial Carcinoma | Neoadjuvant Chemotherapy | Muscle Invasive Bladder CancerKorea, Republic of
-
London Health Sciences CentrePacific Edge LimitedUnknown
-
Peking University Cancer Hospital & InstituteRecruitingUnresectable Hepatocellular Carcinoma | Oligometastatic DiseaseChina
-
AkesoRecruitingUnresectable, Non-metastatic Hepatocellular CarcinomaChina